Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R MacDonald

Showing results (981-990 of 1,067) with videos related to

Pageof 107
Sort By:
Nature Genetics|November 23, 2006
Genome assembly comparison identifies structural variants in the human genomeRazi Khaja, Junjun Zhang, Jeffrey R MacDonald, et al.
Diabetes Care|July 12, 2019
Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection FractionJasper Tromp, Shir Lynn Lim, Wan Ting Tay, et al.
Neuro-Oncology|January 22, 2015
Phase II study of PX-866 in recurrent glioblastomaMarshall W Pitz, Elizabeth A Eisenhauer, Mary V MacNeil, et al.
European Journal of Heart Failure|December 15, 2018
Impact of diabetes and sex in heart failure with reduced ejection fraction patients from the ASIAN-HF registryChanchal Chandramouli, Tiew-Hwa Katherine Teng, Wan Ting Tay, et al.
Cell|December 19, 2017
Intrinsic Immunity Shapes Viral Resistance of Stem CellsXianfang Wu, Viet Loan Dao Thi, Yumin Huang, et al.
European Journal of Heart Failure|May 27, 2015
Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trialMichael R MacDonald, Lilin She, Torsten Doenst, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1996
A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer ConsortiumE C Halperin, J Herndon, S C Schold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O<sup>6</sup>-Methylguanine-DNA Methyltransferase Biomarker AnalysesTimothy Cloughesy, Gaetano Finocchiaro, Cristóbal Belda-Iniesta, et al.
Plos Medicine|September 25, 2019
Association of obesity with heart failure outcomes in 11 Asian regions: A cohort studyChanchal Chandramouli, Wan Ting Tay, Nurul Sahiddah Bamadhaj, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignanciesS G Eckhardt, S D Baker, C D Britten, et al.
Pageof 107

Showing results (981-990 of 1,067) with videos related to

Sort By:
Pageof 107
Nature Genetics|November 23, 2006
Genome assembly comparison identifies structural variants in the human genomeRazi Khaja, Junjun Zhang, Jeffrey R MacDonald, et al.
Diabetes Care|July 12, 2019
Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection FractionJasper Tromp, Shir Lynn Lim, Wan Ting Tay, et al.
Neuro-Oncology|January 22, 2015
Phase II study of PX-866 in recurrent glioblastomaMarshall W Pitz, Elizabeth A Eisenhauer, Mary V MacNeil, et al.
European Journal of Heart Failure|December 15, 2018
Impact of diabetes and sex in heart failure with reduced ejection fraction patients from the ASIAN-HF registryChanchal Chandramouli, Tiew-Hwa Katherine Teng, Wan Ting Tay, et al.
Cell|December 19, 2017
Intrinsic Immunity Shapes Viral Resistance of Stem CellsXianfang Wu, Viet Loan Dao Thi, Yumin Huang, et al.
European Journal of Heart Failure|May 27, 2015
Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trialMichael R MacDonald, Lilin She, Torsten Doenst, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1996
A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer ConsortiumE C Halperin, J Herndon, S C Schold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O<sup>6</sup>-Methylguanine-DNA Methyltransferase Biomarker AnalysesTimothy Cloughesy, Gaetano Finocchiaro, Cristóbal Belda-Iniesta, et al.
Plos Medicine|September 25, 2019
Association of obesity with heart failure outcomes in 11 Asian regions: A cohort studyChanchal Chandramouli, Wan Ting Tay, Nurul Sahiddah Bamadhaj, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignanciesS G Eckhardt, S D Baker, C D Britten, et al.
Pageof 107